Robot-assisted surgery for gynecologic cancers offers outstanding benefits for patients, including a shorter hospital stay and dramatically reduced recovery time due to significantly less pain and discomfort compared with open procedures. The robot-assisted approach also enables many gynecologic cancer patients who do not qualify for traditional laparoscopy to undergo minimally invasive surgery.
This innovative surgical approach offers:
- Shorter hospital stay average 1.5 day stay for robotassisted radical hysterectomy, compared with a four-tofive day hospital stay following open hysterectomy;
- Faster recovery Many patients are able to return to work two weeks following robot-assisted radical hysterectomy;
- Decreased blood loss average of 50ml or less of blood loss and 3cm or smaller incision with robot-assisted radical hysterectomy;
- Minimally invasive option for gynecologic cancer patients with poor vaginal access, obesity, or scarring from prior surgery.
Enhanced Safety
Robot-assisted surgery also offers enhanced safety compared with traditional laparoscopy by providing improved range-of-motion, more finite control of instruments, and a three dimensional view with increased magnification of the patients anatomy.
Expanded Use of Robot-assisted Techniques
In addition to robot-assisted approaches for the treatment of gynecologic cancers, surgeons at Dana-Farber/Brigham and Womens Cancer Center and Brigham and Womens Hospital provide robot-assisted laparoscopic genitourinary surgery, including nerve-sparing radical prostatectomy.
